Diagnostic device for liver failure on FDA fast track Israel Ministry of Foreign Affairs (press release) "Most liver patients are chronic patients," notes Steven Eitan, CEO of Israel's Exalenz Bioscience, a small, Modi'in-based company that has developed the world's first non-invasive diagnostic device for acute liver failure. No similar device exists ... |
